For the quarter ending 2026-03-31, REVB has $15,044,282 in assets. $2,055,329 in debts. $14,113,415 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 14,113,415 | 10,700,331 | 12,708,489 | |
| Prepaid expenses and other current assets | 92,620 | 111,297 | 123,934 | |
| Total current assets | 14,206,035 | 10,811,628 | 12,832,423 | |
| Property and equipment, net | 140,717 | 18,067 | 23,919 | |
| Operating lease right-of-use asset | 666,589 | 722,288 | - | |
| Other assets | 30,941 | 30,941 | - | |
| Total assets | 15,044,282 | 11,582,924 | 12,856,342 | |
| Accounts payable | 828,203 | 577,501 | 1,034,951 | |
| Accrued expenses | 468,082 | 1,397,644 | 819,381 | |
| Warrant liability | - | - | 175 | |
| Operating lease liability | 120,861 | 23,013 | - | |
| Total current liabilities | 1,417,146 | 1,998,158 | 1,854,507 | |
| Operating lease liability, net of current portion | 638,183 | 723,771 | - | |
| Total liabilities | 2,055,329 | 2,721,929 | 1,854,507 | |
| Common stock, 0.001 par value 500,000,000 shares authorized 3,908,420 and 1,583,969 issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 3,908 | 1,584 | 3,586 | |
| Additional paid-in-capital | 65,413,383 | 58,278,698 | 57,906,530 | |
| Accumulated deficit | -52,428,338 | -49,419,287 | -46,908,281 | |
| Total stockholders' equity | 12,988,953 | 8,860,995 | 11,001,835 | |
| Total liabilities and stockholders' equity | 15,044,282 | 11,582,924 | 12,856,342 | |
REVELATION BIOSCIENCES, INC. (REVB)
REVELATION BIOSCIENCES, INC. (REVB)